Registration

HIV AND HEPATITIS POLICY INSTITUTE for HIV AND HEPATITIS POLICY INSTITUTE

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Budget and appropriations for domestic HIV and hepatitis prevention through the CDC and HIV treatment through HRSA; authorizing legislation and Executive Branch programs to support access to HIV prevention medication, treatment, and testing services and viral hepatitis treatment and testing services; and legislation and Executive Branch programs impacting patient access to affordable healthcare and prescription drugs offered through Medicaid, Medicare, and the private insurance market.

LobbyistCovered position, as disclosed
THOMAS MCDANIELS New —
CARL SCHMID New —

Health Issues HCR

Budget and appropriations for domestic HIV and hepatitis prevention through the CDC and HIV treatment through HRSA; authorizing legislation and Executive Branch programs to support access to HIV prevention medication, treatment, and testing services and viral hepatitis treatment and testing services; and legislation and Executive Branch programs impacting patient access to affordable healthcare and prescription drugs offered through Medicaid, Medicare, and the private insurance market.

LobbyistCovered position, as disclosed
THOMAS MCDANIELS New —
CARL SCHMID New —

Insurance INS

Budget and appropriations for domestic HIV and hepatitis prevention through the CDC and HIV treatment through HRSA; authorizing legislation and Executive Branch programs to support access to HIV prevention medication, treatment, and testing services and viral hepatitis treatment and testing services; and legislation and Executive Branch programs impacting patient access to affordable healthcare and prescription drugs offered through Medicaid, Medicare, and the private insurance market.

LobbyistCovered position, as disclosed
THOMAS MCDANIELS New —
CARL SCHMID New —

Medicare/Medicaid MMM

Budget and appropriations for domestic HIV and hepatitis prevention through the CDC and HIV treatment through HRSA; authorizing legislation and Executive Branch programs to support access to HIV prevention medication, treatment, and testing services and viral hepatitis treatment and testing services; and legislation and Executive Branch programs impacting patient access to affordable healthcare and prescription drugs offered through Medicaid, Medicare, and the private insurance market.

LobbyistCovered position, as disclosed
THOMAS MCDANIELS New —
CARL SCHMID New —

Pharmacy PHA

Budget and appropriations for domestic HIV and hepatitis prevention through the CDC and HIV treatment through HRSA; authorizing legislation and Executive Branch programs to support access to HIV prevention medication, treatment, and testing services and viral hepatitis treatment and testing services; and legislation and Executive Branch programs impacting patient access to affordable healthcare and prescription drugs offered through Medicaid, Medicare, and the private insurance market.

LobbyistCovered position, as disclosed
THOMAS MCDANIELS New —
CARL SCHMID New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.